INSPIRE MEDICAL SYSTEMS INC (INSP) Fundamental Analysis & Valuation

NYSE:INSP • US4577301090

Current stock price

54.99 USD
+1.35 (+2.52%)
At close:
54.6694 USD
-0.32 (-0.58%)
After Hours:

This INSP fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. INSP Profitability Analysis

1.1 Basic Checks

  • INSP had positive earnings in the past year.
  • INSP had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: INSP reported negative net income in multiple years.
  • Of the past 5 years INSP 4 years had a positive operating cash flow.
INSP Yearly Net Income VS EBIT VS OCF VS FCFINSP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M

1.2 Ratios

  • The Return On Assets of INSP (16.03%) is better than 95.21% of its industry peers.
  • INSP has a better Return On Equity (18.62%) than 92.55% of its industry peers.
  • INSP's Return On Invested Capital of 5.75% is fine compared to the rest of the industry. INSP outperforms 76.60% of its industry peers.
Industry RankSector Rank
ROA 16.03%
ROE 18.62%
ROIC 5.75%
ROA(3y)6.51%
ROA(5y)-0.53%
ROE(3y)7.56%
ROE(5y)-0.94%
ROIC(3y)N/A
ROIC(5y)N/A
INSP Yearly ROA, ROE, ROICINSP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -500 -1K

1.3 Margins

  • INSP has a Profit Margin of 15.95%. This is amongst the best in the industry. INSP outperforms 92.55% of its industry peers.
  • INSP's Operating Margin of 5.59% is fine compared to the rest of the industry. INSP outperforms 70.74% of its industry peers.
  • With an excellent Gross Margin value of 85.39%, INSP belongs to the best of the industry, outperforming 94.68% of the companies in the same industry.
  • INSP's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 5.59%
PM (TTM) 15.95%
GM 85.39%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.64%
GM growth 5Y0.15%
INSP Yearly Profit, Operating, Gross MarginsINSP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. INSP Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so INSP is destroying value.
  • Compared to 1 year ago, INSP has less shares outstanding
  • Compared to 5 years ago, INSP has more shares outstanding
  • There is no outstanding debt for INSP. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
INSP Yearly Shares OutstandingINSP Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M
INSP Yearly Total Debt VS Total AssetsINSP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

2.2 Solvency

  • INSP has an Altman-Z score of 9.09. This indicates that INSP is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 9.09, INSP belongs to the top of the industry, outperforming 86.70% of the companies in the same industry.
  • INSP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 9.09
ROIC/WACC0.55
WACC10.51%
INSP Yearly LT Debt VS Equity VS FCFINSP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

2.3 Liquidity

  • INSP has a Current Ratio of 6.08. This indicates that INSP is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of INSP (6.08) is better than 79.79% of its industry peers.
  • INSP has a Quick Ratio of 4.56. This indicates that INSP is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of INSP (4.56) is better than 77.66% of its industry peers.
Industry RankSector Rank
Current Ratio 6.08
Quick Ratio 4.56
INSP Yearly Current Assets VS Current LiabilitesINSP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. INSP Growth Analysis

3.1 Past

  • INSP shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 45.09%, which is quite impressive.
  • INSP shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 13.60%.
  • Measured over the past years, INSP shows a very strong growth in Revenue. The Revenue has been growing by 51.20% on average per year.
EPS 1Y (TTM)45.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%40.87%
Revenue 1Y (TTM)13.6%
Revenue growth 3Y30.76%
Revenue growth 5Y51.2%
Sales Q2Q%12.25%

3.2 Future

  • Based on estimates for the next years, INSP will show a quite strong growth in Earnings Per Share. The EPS will grow by 18.33% on average per year.
  • Based on estimates for the next years, INSP will show a quite strong growth in Revenue. The Revenue will grow by 9.35% on average per year.
EPS Next Y-21.33%
EPS Next 2Y1.51%
EPS Next 3Y12.02%
EPS Next 5Y18.33%
Revenue Next Year6.52%
Revenue Next 2Y7.48%
Revenue Next 3Y8.46%
Revenue Next 5Y9.35%

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
INSP Yearly Revenue VS EstimatesINSP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 500M 1B 1.5B
INSP Yearly EPS VS EstimatesINSP Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 2 -2 4 -4 6

More info and screens

Find the best growth stocksShow best growing peers

4

4. INSP Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 21.91, which indicates a rather expensive current valuation of INSP.
  • INSP's Price/Earnings ratio is a bit cheaper when compared to the industry. INSP is cheaper than 76.06% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of INSP to the average of the S&P500 Index (25.60), we can say INSP is valued inline with the index average.
  • A Price/Forward Earnings ratio of 27.85 indicates a quite expensive valuation of INSP.
  • Based on the Price/Forward Earnings ratio, INSP is valued a bit cheaper than the industry average as 72.34% of the companies are valued more expensively.
  • When comparing the Price/Forward Earnings ratio of INSP to the average of the S&P500 Index (22.84), we can say INSP is valued slightly more expensively.
Industry RankSector Rank
PE 21.91
Fwd PE 27.85
INSP Price Earnings VS Forward Price EarningsINSP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of INSP indicates a somewhat cheap valuation: INSP is cheaper than 76.60% of the companies listed in the same industry.
  • 88.83% of the companies in the same industry are more expensive than INSP, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 20.03
EV/EBITDA 16.34
INSP Per share dataINSP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • INSP has a very decent profitability rating, which may justify a higher PE ratio.
  • INSP's earnings are expected to grow with 12.02% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y1.51%
EPS Next 3Y12.02%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. INSP Dividend Analysis

5.1 Amount

  • INSP does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

INSP Fundamentals: All Metrics, Ratios and Statistics

INSPIRE MEDICAL SYSTEMS INC

NYSE:INSP (4/2/2026, 8:04:00 PM)

After market: 54.6694 -0.32 (-0.58%)

54.99

+1.35 (+2.52%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-11
Earnings (Next)05-04
Inst Owners120.91%
Inst Owner Change9.03%
Ins Owners1.39%
Ins Owner Change2.32%
Market Cap1.57B
Revenue(TTM)911.98M
Net Income(TTM)145.42M
Analysts73.6
Price Target91.79 (66.92%)
Short Float %12.69%
Short Ratio2.74
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)176.52%
Min EPS beat(2)81.33%
Max EPS beat(2)271.71%
EPS beat(4)4
Avg EPS beat(4)151.77%
Min EPS beat(4)81.33%
Max EPS beat(4)271.71%
EPS beat(8)8
Avg EPS beat(8)214.54%
EPS beat(12)12
Avg EPS beat(12)205.03%
EPS beat(16)16
Avg EPS beat(16)165.1%
Revenue beat(2)0
Avg Revenue beat(2)-0.44%
Min Revenue beat(2)-0.7%
Max Revenue beat(2)-0.17%
Revenue beat(4)1
Avg Revenue beat(4)-0.11%
Min Revenue beat(4)-0.7%
Max Revenue beat(4)1.13%
Revenue beat(8)3
Avg Revenue beat(8)0.06%
Revenue beat(12)6
Avg Revenue beat(12)1.03%
Revenue beat(16)10
Avg Revenue beat(16)3.19%
PT rev (1m)-3.94%
PT rev (3m)-36.4%
EPS NQ rev (1m)-16.09%
EPS NQ rev (3m)-389.75%
EPS NY rev (1m)12.01%
EPS NY rev (3m)11.34%
Revenue NQ rev (1m)-0.82%
Revenue NQ rev (3m)-5.59%
Revenue NY rev (1m)-0.46%
Revenue NY rev (3m)-3.92%
Valuation
Industry RankSector Rank
PE 21.91
Fwd PE 27.85
P/S 1.72
P/FCF 20.03
P/OCF 13.44
P/B 2.01
P/tB 2.01
EV/EBITDA 16.34
EPS(TTM)2.51
EY4.56%
EPS(NY)1.97
Fwd EY3.59%
FCF(TTM)2.74
FCFY4.99%
OCF(TTM)4.09
OCFY7.44%
SpS31.9
BVpS27.32
TBVpS27.32
PEG (NY)N/A
PEG (5Y)N/A
Graham Number39.28
Profitability
Industry RankSector Rank
ROA 16.03%
ROE 18.62%
ROCE 6.28%
ROIC 5.75%
ROICexc 9.27%
ROICexgc 9.27%
OM 5.59%
PM (TTM) 15.95%
GM 85.39%
FCFM 8.61%
ROA(3y)6.51%
ROA(5y)-0.53%
ROE(3y)7.56%
ROE(5y)-0.94%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.64%
GM growth 5Y0.15%
F-Score7
Asset Turnover1.01
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 275.84%
Cap/Sales 4.22%
Interest Coverage 371.93
Cash Conversion 180.21%
Profit Quality 53.97%
Current Ratio 6.08
Quick Ratio 4.56
Altman-Z 9.09
F-Score7
WACC10.51%
ROIC/WACC0.55
Cap/Depr(3y)567.8%
Cap/Depr(5y)515.09%
Cap/Sales(3y)4.29%
Cap/Sales(5y)3.42%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)45.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%40.87%
EPS Next Y-21.33%
EPS Next 2Y1.51%
EPS Next 3Y12.02%
EPS Next 5Y18.33%
Revenue 1Y (TTM)13.6%
Revenue growth 3Y30.76%
Revenue growth 5Y51.2%
Sales Q2Q%12.25%
Revenue Next Year6.52%
Revenue Next 2Y7.48%
Revenue Next 3Y8.46%
Revenue Next 5Y9.35%
EBIT growth 1Y41.21%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year683.86%
EBIT Next 3Y109.9%
EBIT Next 5Y69.99%
FCF growth 1Y-13.88%
FCF growth 3Y216.73%
FCF growth 5YN/A
OCF growth 1Y-10.19%
OCF growth 3Y116.23%
OCF growth 5YN/A

INSPIRE MEDICAL SYSTEMS INC / INSP Fundamental Analysis FAQ

What is the ChartMill fundamental rating of INSPIRE MEDICAL SYSTEMS INC (INSP) stock?

ChartMill assigns a fundamental rating of 6 / 10 to INSP.


Can you provide the valuation status for INSPIRE MEDICAL SYSTEMS INC?

ChartMill assigns a valuation rating of 4 / 10 to INSPIRE MEDICAL SYSTEMS INC (INSP). This can be considered as Fairly Valued.


What is the profitability of INSP stock?

INSPIRE MEDICAL SYSTEMS INC (INSP) has a profitability rating of 6 / 10.


Can you provide the expected EPS growth for INSP stock?

The Earnings per Share (EPS) of INSPIRE MEDICAL SYSTEMS INC (INSP) is expected to decline by -21.33% in the next year.